Precision Biosensor Past Earnings Performance

Past criteria checks 0/6

Precision Biosensor's earnings have been declining at an average annual rate of -17.8%, while the Medical Equipment industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 19.1% per year.

Key information

-17.8%

Earnings growth rate

-11.6%

EPS growth rate

Medical Equipment Industry Growth	22.7%
Revenue growth rate	19.1%
Return on equity	-29.3%
Net Margin	-44.0%
Last Earnings Update	30 Sep 2024

Recent past performance updates

Recent updates

Precision Biosensor, Inc.'s (KOSDAQ:335810) Business Is Yet to Catch Up With Its Share Price

Dec 16

Some Confidence Is Lacking In Precision Biosensor, Inc. (KOSDAQ:335810) As Shares Slide 30%

Sep 10

We Think Precision Biosensor (KOSDAQ:335810) Has A Fair Chunk Of Debt

Aug 26

Subdued Growth No Barrier To Precision Biosensor, Inc.'s (KOSDAQ:335810) Price

Jul 02

Revenue & Expenses Breakdown

How Precision Biosensor makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A335810 Revenue, expenses and earnings (KRW Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Sep 24	18,215	-8,009	6,843	3,707
30 Jun 24	17,135	-6,806	7,038	3,545
31 Mar 24	18,103	-5,838	7,412	3,353
31 Dec 23	20,391	-4,490	7,529	3,196
30 Sep 23	20,570	-4,231	7,611	2,995
30 Jun 23	20,885	-5,056	7,512	3,037
31 Mar 23	19,787	-7,016	7,461	2,840
31 Dec 22	20,458	-6,806	7,601	2,611
30 Sep 22	22,808	-6,251	7,495	2,463
30 Jun 22	23,500	-4,733	7,814	1,752
31 Mar 22	21,233	-3,308	7,742	1,509
31 Dec 21	15,887	-4,152	6,305	1,958
30 Sep 21	14,255	-2,250	5,414	2,084
30 Jun 21	11,111	-2,215	4,967	2,084
31 Mar 21	9,447	-4,947	4,158	2,240
31 Dec 20	8,685	-4,953	3,907	2,045
30 Sep 20	5,292	-6,221	3,697	1,934
31 Dec 19	6,205	-405	3,217	1,665
31 Dec 18	4,588	-4,040	2,608	1,831
31 Dec 17	4,406	-2,455	2,402	1,672
31 Dec 16	4,913	-1,294	2,589	1,670
31 Dec 15	1,387	-1,425	1,298	578

Quality Earnings: A335810 is currently unprofitable.

Growing Profit Margin: A335810 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A335810 is unprofitable, and losses have increased over the past 5 years at a rate of 17.8% per year.

Accelerating Growth: Unable to compare A335810's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A335810 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-16.5%).

Return on Equity

High ROE: A335810 has a negative Return on Equity (-29.34%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/29 02:41
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Precision Biosensor, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution